BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10205214)

  • 1. The natural history of histologically proved drug induced liver disease.
    Aithal PG; Day CP
    Gut; 1999 May; 44(5):731-5. PubMed ID: 10205214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.
    De Valle MB; Av Klinteberg V; Alem N; Olsson R; Björnsson E
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1187-95. PubMed ID: 17014577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver damage -- a three-year study of patients from one gastroenterological department.
    Hartleb M; Biernat L; Kochel A
    Med Sci Monit; 2002 Apr; 8(4):CR292-6. PubMed ID: 11951073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P; Mouallem M; Bruck R; Hassin D; Tanay A; Brickman CM; Farfel Z; Bar-Meir S
    Isr Med Assoc J; 1999 Oct; 1(2):89-91. PubMed ID: 10731303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Cholestatic Liver Injury From Hydralazine Intake.
    Harati H; Rahmani M; Taghizadeh S
    Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with mild to moderate drug-induced liver injury.
    Björnsson E; Kalaitzakis E; Av Klinteberg V; Alem N; Olsson R
    Aliment Pharmacol Ther; 2007 Jul; 26(1):79-85. PubMed ID: 17555424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole-induced autoimmune chronic hepatitis.
    Meunier L; Ursic-Bedoya J; Pageaux GP; Larrey D
    Liver Int; 2018 Jun; 38(6):995-999. PubMed ID: 29532602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naproxen-induced liver injury.
    Ali S; Pimentel JD; Ma C
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):552-6. PubMed ID: 21947732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
    Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
    Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid therapy for a case of severe drug-induced cholestasis.
    Giannattasio A; D'Ambrosi M; Volpicelli M; Iorio R
    Ann Pharmacother; 2006 Jun; 40(6):1196-9. PubMed ID: 16720710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia.
    Topley JM; Benson J; Squier MV; Chessells JM
    Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.
    Runyon BA; LaBrecque DR; Anuras S
    Am J Med; 1980 Aug; 69(2):187-94. PubMed ID: 7405944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug- and herb-induced liver injury: a case series from a single center.
    Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
    Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenoxicam-associated hepatic injury: a case report and review.
    Katsinelos P; Katsos I; Patsiaoura K; Xiarchos P; Goulis I; Eugenidis N
    Eur J Gastroenterol Hepatol; 1997 Apr; 9(4):403-6. PubMed ID: 9160206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.